stockportfolio.pro
Vir Biotechnology, Inc. Revenue 2017–2025
Vir Biotechnology, Inc. (VIR) annual revenue by fiscal year, computed from SEC filings. Compound growth +49.8%/yr over 8 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $68.56M | -7.6% |
| FY 2024 | $74.20M | -13.9% |
| FY 2023 | $86.18M | -94.7% |
| FY 2022 | $1.62B | +47.5% |
| FY 2021 | $1.10B | +1334.4% |
| FY 2020 | $76.37M | +843.9% |
| FY 2019 | $8.09M | -24.2% |
| FY 2018 | $10.67M | +293.9% |
| FY 2017 | $2.71M | — |
Source: Vir Biotechnology, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Vir Biotechnology, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVir Biotechnology, Inc. — frequently asked questions
What is Vir Biotechnology, Inc.'s revenue?
Vir Biotechnology, Inc. (VIR) reported revenue of $68.56M for fiscal year 2025, per its SEC filings.
How has Vir Biotechnology, Inc.'s revenue changed over time?
Between fiscal 2017 and 2025, VIR's revenue grew at roughly 49.8% per year (compound annual rate), from $2.71M to $68.56M.
Where does this data come from?
Figures are computed from Vir Biotechnology, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.